anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Calliditas Therapeutics · pitchdeck

Calliditas Therapeutics | IPO Presentation Deck | 38 slides

38 pages · 5 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Calliditas Therapeutics | IPO Presentation Deck | 38 slides

Calliditas Therapeutics · 2020-06
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 10 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 2 slides 100% 2/2 slides 100% 2/2 slides · 8 hits
— 0/2 slides
— 0/2 slides
50% 1/2 slides 100% 2/2 slides
— 0/2 slides
Solution 2 slides 100% 2/2 slides 100% 2/2 slides · 12 hits
— 0/2 slides
— 0/2 slides
50% 1/2 slides 100% 2/2 slides
— 0/2 slides
Market Size 2 slides 100% 2/2 slides 100% 2/2 slides · 8 hits
— 0/2 slides
— 0/2 slides
— 0/2 slides
100% 2/2 slides 100% 2/2 slides Product 2 slides 100% 2/2 slides 100% 2/2 slides · 11 hits
— 0/2 slides
50% 1/2 slides
— 0/2 slides
100% 2/2 slides
— 0/2 slides
Team 2 slides 100% 2/2 slides 100% 2/2 slides · 10 hits
— 0/2 slides
50% 1/2 slides
— 0/2 slides
100% 2/2 slides
— 0/2 slides

Slide inventory

38
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
plan_implementation
Open slide detail
04
other
Open slide detailBeat · Team
05
The slide serves as a company overview/fact sheet.summarize
Open slide detailBeat · Team
06
The slide uses a Gantt-style chart to show clinical trial phases.plan_implementation
Open slide detail
07
The slide uses a numbered list format to present key value propositions.summarize
Open slide detail
08
frame_problem
Open slide detailBeat · Problem
09
The slide uses a linear process flow to explain a complex medical mechanism.frame_problem
Open slide detailBeat · Problem
10
Includes a diagram of the digestive system metabolism and a graph showing drug concentration over time/location.present_solution
Open slide detailBeat · Solution
11
The slide uses a structured list format to categorize different types of competitive moats (regulatory, patent, strategic, and operational).present_solution
Open slide detailBeat · Solution
12
Includes two bar charts showing primary and secondary endpoint results.show_traction
Open slide detailBeat · Product
13
The slide presents clinical trial safety data comparing Placebo, Nefecon 16mg, and Nefecon 8mg.analyze_data
Open slide detailBeat · Product
14
Data presented as box plots comparing End of Treatment (EoT) and Last follow-up.analyze_data
Open slide detail
15
Data derived from post-hoc analyses. HbA1c is a measure of diabetes risk.analyze_data
Open slide detail
16
The slide uses a process flow diagram to illustrate the clinical trial structure (Screening, Part A, Part B).plan_implementation
Open slide detail
17
The slide outlines clinical trial parameters for a drug candidate (Nefecon) targeting IgA Nephropathy.present_framework
Open slide detail
18
The slide uses a bulleted list to detail operational resilience in a clinical trial setting.establish_context
Open slide detail
19
The slide uses a combination of a horizontal timeline and callout boxes to detail specific clinical trial milestones.plan_implementation
Open slide detail
20
Focuses on clinical trial progression timelines and methodology.plan_implementation
Open slide detail
21
The slide uses a matrix-like layout to categorize strategic pillars.plan_implementation
Open slide detail
22
The slide uses a two-column layout to contrast market opportunity with the societal cost of the disease.size_opportunity
Open slide detailBeat · Market SizeLoop · Cost Of Inaction
23
The slide presents findings from both qualitative interviews and a quantitative survey to validate market demand.analyze_data
Open slide detailBeat · Market SizeLoop · Cost Of Inaction
24
The slide outlines specific payor requirements (prior auth, nephrologist prescription, etc.) and strategic opportunities to improve the value proposition.summarize
Open slide detail
25
The network diagram illustrates the connectivity between KOLs (orange) and the broader nephrologist community (blue).analyze_data
Open slide detail
26
The slide uses a structured table format to align market opportunity with strategic execution.plan_implementation
Open slide detail
27
The slide uses a bulleted list to explain the pathophysiology of PBC and AIH.frame_problem
Open slide detail
28
The slide highlights the lack of targeted anti-inflammatory therapies for PBC.frame_problem
Open slide detail
29
Includes prevalence map and clinical statistics on treatment side effects and relapse rates.frame_problem
Open slide detail
30
plan_implementation
Open slide detail
31
Includes checkmarks for completed items; 2020 is marked with an asterisk regarding COVID-19 uncertainty.plan_implementation
Open slide detailLoop · Why Now
32
The slide uses a numbered list format to present key value drivers including clinical status, regulatory pathway, and market opportunity.summarize
Open slide detailLoop · Why Now
33
appendix
Open slide detail
34
The chart demonstrates a strong correlation (R^2=0.90) between proteinuria reduction and ESRD risk reduction, supporting the use of proteinuria as a surrogate eanalyze_data
Open slide detail
35
The table shows percentage changes or values for various renal markers. The 16mg dose consistently shows stronger efficacy (higher percentage reductions in protanalyze_data
Open slide detail
36
other
Open slide detail
37
other
Open slide detail
38
The slide uses a 'hub-spoke' visual arrangement for the board members, though they are presented as a list of cards.other
Open slide detail